GenScript Biotech Corporation Reports FY 2024 Results
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: PR Newswire
Strategic deconsolidation of Legend Biotech unlocked significant value, while core businesses experienced rapid growth.PISCATAWAY, N.J., March 12, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HKEX: 1548.HK), a leading global technology and service provider of life science R&D and manufacturing reported its financial results for the full year ended on December 31, 2024.FY 2024 Result HighlightsDeconsolidation of cell therapy business resulted in a gain of $3.2 Billion.Revenue from the continuing operations (sans cell therapy business) was $594.5 Million compared to $560.5 Million for the year ended December 31, 2023 (the "Prior Period").Profit of the Group has increased to approximately $2.9 Billion, whilst the loss of the Group was approximately US$355.1 million for the Prior Period.The adjusted net profit of the Group from continuing operations was approximately $59.8 Million compared to $58.1 Million for the Prior Period.Significant investments were made in manufacturing and
Show less
Read more
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- Here is Why Legend Biotech (LEGN) Offers Such Promising Upside [Yahoo! Finance]Yahoo! Finance
- Legend Biotech (NASDAQ:LEGN) was given a new $74.00 price target on by analysts at Cantor Fitzgerald.MarketBeat
- Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Legend Biotech (NASDAQ:LEGN) was given a new $50.00 price target on by analysts at Morgan Stanley.MarketBeat
LEGN
Sec Filings
- 12/8/25 - Form 6-K
- 11/17/25 - Form 144
- 11/12/25 - Form 6-K
- LEGN's page on the SEC website